Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02821689 |
|
Recruitment Status : Unknown
Verified June 2016 by Shuang Ye, RenJi Hospital.
Recruitment status was: Not yet recruiting
First Posted : July 1, 2016
Last Update Posted : July 1, 2016
|
Sponsor:
RenJi Hospital
Information provided by (Responsible Party):
Shuang Ye, RenJi Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | June 2017 |
| Estimated Study Completion Date : | June 2018 |